vimarsana.com

Latest Breaking News On - Sangamo therapeutics company profile - Page 1 : vimarsana.com

Sangamo Therapeutics (NASDAQ:SGMO) Earns Sell Rating from Analysts at StockNews com

StockNews.com initiated coverage on shares of Sangamo Therapeutics (NASDAQ:SGMO – Free Report) in a research note released on Saturday. The firm issued a sell rating on the biopharmaceutical company’s stock. Several other equities analysts have also issued reports on the company. Royal Bank of Canada reaffirmed a sector perform rating and set a $2.00 price […]

Sangamo Therapeutics (NASDAQ:SGMO) Now Covered by StockNews com

StockNews.com started coverage on shares of Sangamo Therapeutics (NASDAQ:SGMO – Free Report) in a research note released on Saturday morning. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Several other research firms have also issued reports on SGMO. HC Wainwright restated a buy rating and set a $5.00 price target (up previously […]

Sangamo Therapeutics (NASDAQ:SGMO) Coverage Initiated at StockNews com

Sangamo Therapeutics (NASDAQ:SGMO) Coverage Initiated at StockNews com
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Sangamo Therapeutics (NASDAQ:SGMO) Receives New Coverage from Analysts at StockNews com

Sangamo Therapeutics (NASDAQ:SGMO) Receives New Coverage from Analysts at StockNews com
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Sangamo Therapeutics (NASDAQ:SGMO) Earns Sell Rating from Analysts at StockNews com

Sangamo Therapeutics (NASDAQ:SGMO) Earns Sell Rating from Analysts at StockNews com
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.